| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |